Mass Spectrometers

Amrita Cheema, PhD, associate professor and codirector of the Proteomics and Metabolomics Shared Resource at Georgetown University Medical Center, talks to contributing editor Tanuja Koppal, PhD, about the growing use of mass spectrometry as a tool for detecting biomarkers for early prediction and diagnosis of disease, leading to personalized therapy. She highlights that improvements in software
and hardware have led to better resolution and specificity, which in turn have increased the use of this technology for biomarker discovery and will potentially help pave its path into the clinic as a diagnostic tool.

According to a report from Persistence Market Research, Mass Spectrometry Technologies Market Assessment Report—Global Size, Share, Competitive Landscape, Future Prospects and Forecast from 2013-2017, mass spectrometry (MS) is one of the few instrumentation markets that has recovered fully from the last recession.

Anasys Instruments Corp. has licensed a Department of Energy Oak Ridge National Laboratory technology that allows for simultaneous chemical and physical characterization and could lead to advances in materials and drug development.











